Table 5 Blood products and hemostatics according to patients in the state of moderate or severe shock
| Â | ER | |
|---|---|---|
BE -2 to -6 | BE < -6 | |
pRBC transfusion, n (%) | 178/257 (69.3) | 207/258 (80.2) |
pRBC mass transfusion ≥10, n (%) | 58/257 (22.6) | 109/258 (42.2) |
pRBC, median (IQR) | 4.0 (0–8.0) | 7.0 (2.0–16.5) |
FFP transfusion, n (%) | 145/257 (56.4) | 176/271 (68.2) |
FFP, median (IQR) | 3.0 (0–7.11) | 6.0 (0–14.3) |
FFP:pRBC ratio | 0.95 | 0.80 |
Platelet concentrates, n (%) | 46/257 (17.9) | 93/258 (36.0) |
Platelet concentrates, median (IQR) | 0 (0–0) | 0 (0–1.8) |
Platelet concentrates, mean (SD) | 0.4 (1.2) | 1.3 (3.9) |
Fibrinogen, n (%) | 40/171 (23.4) | 62/176 (35.2) |
PPSB, n (%) | 30/171 (17.5) | 42/176 (23.9) |
Recombinant factor VIIa, n (%) | 9/171 (5.3) | 16/176 (9.1) |
Antifibrinolytics, n (%) | 13/171 (7.6) | 21/176 (11.9) |
Others, n (%) | 21/171 (12.3) | 32/176 (18.2) |